Search results for oligos
oligos community
One keyword maps to one global community path.
People
Not Found
Tweets including oligos
A free online book on the chemistry and biology of nucleic acids, for anyone working with or with an interest in nucleic acids in #chemistry# and #biology#.
#oligoneucleotides# #aptamers#
#oligos# #DNAsequencing# #nextgensequencing#
Show more
Oligonucleotide drug slows Alzheimer’s decline across every dose tested in Phase 2 and reframes the field’s central therapeutic target.
#longevity# #geroscience# #Alzheimers# #oligonucleotide# #Phase2#
Show more
Omigosh ;///;
I just finished my 12hr anniversary/debut stream and...we weren't on the front page nor doing asmr/or had huge raids but there were so many of you--!! TYSM for dropping by...truly! I love you all❤️
Here's my letter for Lunes (long version 🔊sound ON)!
#HanyaLIVE#
Show more
Discover emerging science across oligonucleotide therapeutics, RNA medicines, and advanced delivery technologies at OTDC 2027.
📅 May 11–12, 2027
📍 Boston, Massachusetts, USA
🌐 Hybrid Event
🔗
#OTDC2027# #RNA# #OligonucleotideTherapeutics# #DrugDelivery#
Show more
Advancing cancer treatment through oligonucleotide-based therapies from siRNA & ASOs to innovative delivery systems driving precision oncology.
🌍OTDC 2026
🗓️ 25–26 May 2026 | 📍 Rome, Italy
🔗
#OTDC2026# #RNATherapeutics# #Oligonucleotides# #CancerResearch#
Show more
Systemic delivery of oligonucleotide drugs faces major hurdles nuclease degradation, RES uptake, renal clearance, BBB barriers & endosomal escape.
📢Exciting discussions ahead at OTDC 2026,
May 25,26 in Rome,Italy.
🔗
#OTDC2026# #Oligonucleotides# #RNAtech#
Show more
AI is transforming oligonucleotide design and drug delivery excited to be part of it!
📅 Conference: OTDC (2026)
📍 Location: Rome, Italy
🗓 Dates: May 25–26, 2026
🌐 Website:
#RNAtherapeutics# #DrugDelivery# #AIinPharma# #Oligonucleotides# #HealthcareAI#
Show more
Advances in Sustainable #Oligonucleotide# Manufacturing
...
#Oligonucleotides#
#RNAtherapeutics#
......
Delivery of Oligonucleotides to the Liver With GalNAc: From Research to Registered Therapeutic Drug - PubMed
DRAM is one of tech's tightest oligopolies.
DRAM's top three holdings - Micron (28.05%), SK Hynix (27.64%), and Samsung (16.27%) - command nearly 72% of the portfolio, mirroring real DRAM supply concentration.
For amplified exposure, explore Leverage Shares 3x Long Memory (DRM3).
Show more
